Matthew C. Foote
Experienced in Neuroendocrine Tumor

Matthew C. Foote

199 Ipswich Road, 
Woolloongabba, QLD, AU 
Experienced in Neuroendocrine Tumor
199 Ipswich Road, 
Woolloongabba, QLD, AU 
OverviewLocationsClinical Research

Overview

Matthew Foote practices in Woolloongabba, Australia. Mr. Foote is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Brain Tumor, Bone Tumor, Lymphadenectomy, and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 121 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles and participated in 2 clinical trials in the study of Neuroendocrine Tumor.

Gender
Male

Locations

199 Ipswich Road, Woolloongabba, QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Radiation, Drug
Study Drug: Dabrafenib and Trametinib (Combination)
Study Phase: Phase 1/Phase 2
A Randomised Trial of Post-operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck
A Randomised Trial of Post-operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Other, Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

121 Total Publications

Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial.
Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: February 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Foote's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile